EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Merck
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore
Articles
Kinase Inhibitors as Antiviral Agents
The emergence of virus infections is a serious issue and the development of broadly acting antivirals has heightened concern for future viral epidemics The majority of these drugs operate directly on the proteins encoded by the individual viral genome However they have the following disadvantages i limited treatment coverage which does not address
Research Insights
DNA Oligonucleotides Block Viral Entry of SARS-CoV-2 Omicron Variants
Successful viruses including SARSCoV antagonize and evade immune detection to establish infection As population immunity to the ancestral strain has risen new variantsparticularly Omicron
Case Studies
Open Innovation in Pharmaceutical Industry: A Case Study by Eli Lilly
Abstract Interest on Open Innovation paradigm has seen a phenomenal increase since last two decades especially when Henry Chesbrough coined this term in triggering the creation of a new whole body of knowledge However all of his research work could not come up with a standardized allinone theory Instead we find a heterogeneous series of models tha
Techno Trends
Biogen Developed SKYCLARYS® (omaveloxolone), the First Therapy to treat Friedreich’s Ataxia
Biogen has developed SKYCLARYS marking a significant breakthrough as the inaugural therapeutic option for addressing Friedreichs ataxia in adults and adolescents aged years and older
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Beyond The Needle
Dr. Sanjesh Kumar is an Assistant Professor at Chandigarh University Uttar Pradesh with a Ph.D. in Pharmacology. An award-winning academician specialized in neurodegenerative disorders and advanced drug delivery, he has authored over 45 high-impact publications and holds multiple patents, seamlessly bridging the gap between clinical research and classroom education.
Dr. Mansi Singh is an academician and researcher serving as Guest Faculty at Babasaheb Bhimrao Ambedkar University, holding a Ph.D. in Pharmacology. A NET and GPAT qualified expert, she is specialized in neuropharmacology and toxicology. She has over six years of teaching experience and has authored more than 40 publications, copyright and multiple patents.
Demystifying Lead-time bias and Length-time bias in Clinical Trials
Jefry Winner G has completed his MBBS from Vinayaka Missions Medical College. He is currently pursuing a Doctorate of Medicine in Pharmacology at JIPMER Puducherry. He is interested in clinical research and is currently involved in an academic clinical trial involving Epilepsy. He has four years of clinical experience in healthcare and Academia. His area of interest includes Clinical trials, Pharmacotherapeutics, Drug safety, and clinical pharmacology. He also has over 15 publications in peer-reviewed journals.
Allosteric Modulation: A Paradigm Shift in Pharmaceutical Innovation
Dr. Parth Sarthi Sen Gupta is a Computational Biologist specializing in computational drug and vaccine design, with a focus on allosteric modulation. He is an Associate professor in School of Biosciences and Bioengineering, D Y Patil International University. He has published more than 50 research articles and book chapter in reputed peer reviewed Journals. His research work on COVID19 has been highlighted by various national and international news agencies and recognized by World health organizations.
Repurposed Drugs against the Latest Variants of Concerns of SARS-CoV-2
Sinosh Skariyachan Ph.D. is presently working as Assistant Professor in Microbiology at St. Pius X College, Rajapuram (Aided by Govt. of Kerala, India), Kasaragod, Kerala, India with more than 17 years of experience in teaching and research. One of his key areas of research is computational drug discovery and medicinal chemistry. He has published more than 75 international papers, book chapters, and text books. He is the editor of prestigious journals such as Computers in Biology and Medicine (Elsevier), Frontiers in Microbiology and a referee for more than 125 international journals. He received several awards and grants.
Chemistry & AI
Dr. Ashok Kumar FRSC, President of the Centre for Research & Development at Ipca, earned his PhD from CDRI with Dr. Nityanand and post-doctoral experience from Sussex University with Nobel Laureate Prof. Cornforth. His interests include Chemical, Biotechnological & NDDR research and also integrating spirituality, philosophy, and common sense in his professional and personal life.
press releasesRead more...
Expert Shares Why ADC Development is Demanding a New Level of Bioconjugation Expertise
Antibodydrug conjugates have moved from a promising concept to one of the most actively developed drug classes in oncology Behind that progress lies a manufacturing challenge that is becoming more demanding by the year
Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
Hengrui Pharma SH HK today announced that it has entered into a license agreement with Novo Nordisk Novo for HRS a phase Iready glucagonlike peptide receptor GLPR
Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline
Quotient Sciences a global integrated CRDMO contract research development and manufacturing organization and Acesion Pharma a Copenhagenbased biotech company developing treatments
Chugai and InxMed Enter into a Worldwide License Agreement for SPYK04, a RAF-MEK Molecular Glue
Chugai Pharmaceutical Co Ltd TOKYO hereafter Chugai and InxMed Hong Kong Limited hereafter InxMed today announced that they have entered into a worldwide license
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
Knight Therapeutics Inc Knight TSX GUD a panAmerican exUS pharmaceutical company announced today the signing of an exclusive distribution agreement with Kyowa Kirin International KKI a
BIX 2026 Names Canada as Country of Honor Showcasing Bioindustry Trends from BCI To Biotech Foods
BIOPLUSINTERPHEX KOREA BIX Koreas largest biotechnology and pharmaceutical convention will be held at COEX in Seoul from October to Supported by the Ministry of Trade Industry and Resources this years BIX will feature over companies from around the world Canada will participate as the Country o...
EventsRead more...
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
01 - 01
Oct 2026Articulate 2026: The Communication Revolution
Philadelphia, United States
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
LATEST NEWSRead more...
CAS and Novartis Collaborate to Advance AI-Ready Reaction Data
CAS has announced a collaboration with Novartis Biomedical Research to improve access to reaction data and support the use of artificial intelligence in scientific research
AbbVie Partners with Valkai to Expand AI Use in Clinical Development
AbbVie has partnered with Valkai to expand the use of AI across selected areas of clinical development
Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration
Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling
TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation
TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures
SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy
SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA
Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration
Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration